# US 2006/0153875 A1 · Novel brachyspira hyodyseteriae vaccine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153875 A1
- Document ID: US20060153875A1
- Status: Published application
- Kind: A1
- Application number: 10/521,693
- Filed: 2003-07-11
- Published: 2006-07-13
- Earliest claimed: 2002-07-17
- Inventors: Ben Adler; Paul Cullen; Scott Coutts; Dieter Bulach; Ruud Phillip Segers
- Web page: https://patentgrep.com/patent/US20060153875A1

## CPC

- C07K 14/20: from Spirochaetales (O), e.g. Treponema, Leptospira
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- A61K 2039/505: {comprising antibodies}
- A61K 2039/523: {expressing foreign proteins}
- A61K 2039/53: {DNA (RNA) vaccination}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention relates to nucleic acid sequences encoding a 61 kD and a 20 kD Brachyspira hyodysenteriae lipoprotein and to parts of such nucleic acid sequences that encode an immunogenic fragment of such lipoproteins, and to DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof. The invention also relates to a 61 kD and a 20 kD Brachyspira hyodysenteriae lipoprotein and immunogenic parts thereof encoded by such sequences. Furthermore, the present invention relates to vaccines comprising such nucleic acid sequences and parts thereof, DNA fragments, recombinant DNA molecules, live recombinant carriers and host cells comprising such nucleic acid sequences or such parts thereof, lipoproteins or immunogenic parts thereof and antibodies against such lipoproteins or immunogenic parts thereof. Also, the invention relates to the use of said lipoproteins in vaccines and for the manufacture of vaccines. Moreover, the invention relates to the use of said nucleic acid sequences, lipoproteins or antibodies for diagnostic or vaccination purposes. Finally the invention relates to diagnostic kits comprising such a nucleic acid, lipoprotein or antibodies against such lipoprotein.

## Claims

### Claim at position 1

1-4. (canceled)

### Claim 5 (depends on 25)

A DNA fragment comprising a nucleic acid sequence according to claim 25.

### Claim 6 (depends on 25)

A recombinant DNA molecule comprising a nucleic acid sequence according to claim 25, under the control of a functionally linked promoter.

### Claim 7 (depends on 25)

A live recombinant carrier comprising a nucleic acid sequence according to claim 25.

### Claim 8 (depends on 25)

A host cell comprising a nucleic acid sequence according to claim 25.

### Claim at position 6

9-18. (canceled)

### Claim 19 (depends on 29)

A vaccine for combating Brachyspira hyodysenteriae infection comprising antibodies against a lipoprotein according to claim 29, and a pharmaceutically acceptable carrier.

### Claim 20 (depends on 19)

The vaccine according to claim 19, comprising an adjuvant.

### Claim 21 (depends on 19)

The vaccine according to claim 19, comprising an additional antigen derived from another swine pathogen, an antibody against such an antigen or genetic information encoding said antigen.

### Claim 22 (depends on 21)

The vaccine according to claim 21, wherein said pathogen is selected from the group consisting of Pseudorabies virus, Porcine influenza virus, Porcine parvo virus, Transmissible gastro-enteritis virus, Rotavirus, Escherichia coli, Erysipelo rhusiopathiae, Bordetella bronchiseptica, Salmonella cholerasuis, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis, Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae.

### Claim 23

(canceled)

### Claim 24 (depends on 25)

A diagnostic kit for detecting Brachyspira hyodysenteriae or antibodies thereto, comprising a nucleic acid sequence according to claim 25, or a lipoprotein or antigenic fragment thereof encoded by said sequence, or antibodies that are reactive with said lipoprotein.

### Claim 25

A nucleic acid sequence encoding an immunogenic 61 kD Brachyspira hyodysenteriae lipoprotein, as measured by SDS-PAGE.

### Claim 26 (depends on 25)

The nucleic acid sequence of claim 25, wherein the 61 kD Brachyspira hyodysenteriae lipoprotein has the amino acid sequence of SEQ ID NO:2.

### Claim 27

A nucleic acid sequence encoding an immunogenic 20 kD Brachyspira hyodysenteriae lipoprotein, as measured by SDS-PAGE.

### Claim 28 (depends on 27)

The nucleic acid sequence of claim 27, wherein the 20 kD Brachyspira hyodysenteriae lipoprotein has the amino acid sequence of SEQ ID NO:4.

### Claim 29

An isolated immunogenic Brachyspira hyodysenteriae lipoprotein of 61 kD, as measured by SDS-PAGE.

### Claim 30 (depends on 29)

The isolated immunogenic Brachyspira hyodysenteriae lipoprotein of claim 29 having the amino acid sequence of SEQ ID NO: 2.

### Claim 31

An isolated immunogenic Brachyspira hyodysenteriae lipoprotein of 20 kD, as measured by SDS-PAGE.

### Claim 32 (depends on 31)

The isolated immunogenic Brachyspira hyodysenteriae lipoprotein of claim 31 having the amino acid sequence of SEQ ID NO:4.

### Claim 33 (depends on 29)

An immunogenic composition comprising an effective amount of the Brachyspira hyodysenteriae lipoprotein of claim 29 and a pharmaceutically acceptable carrier.

### Claim 34 (depends on 31)

An immunogenic composition comprising an effective amount of the Brachyspira hyodysenteriae lipoprotein of claim 31 and a pharmaceutically acceptable carrier.

### Claim 35 (depends on 25)

An immunogenic composition comprising an immunogenically effective amount of a nucleic acid sequence selected from the group consisting of a DNA fragment, a recombinant DNA molecule and a live recombinant carrier, or host cell comprising said nucleic acid sequence, wherein said nucleic acid sequence is the nucleic acid sequence of claim 25.

### Claim 36 (depends on 27)

An immunogenic composition comprising an immunogenically effective amount of a nucleic acid sequence selected from the group consisting of a DNA fragment, a recombinant DNA molecule and a live recombinant carrier, or a host cell comprising said nucleic sequence, wherein said nucleic acid sequence is the nucleic acid sequence of claim 27.

### Claim 37 (depends on 27)

A DNA fragment comprising a nucleic acid sequence according to claim 27.

### Claim 38 (depends on 27)

A recombinant DNA molecule comprising a nucleic acid sequence according to claim 27, under the control of a functionally linked promoter.

### Claim 39 (depends on 27)

A live recombinant carrier comprising a nucleic acid sequence according to claim 27.

### Claim 40 (depends on 27)

A host cell comprising a nucleic acid sequence according to claim 27.

### Claim 41 (depends on 27)

A diagnostic kit for detecting Brachyspira hyodysenteriae or antibodies thereto, comprising a nucleic acid sequence according to claim 27, or a lipoprotein or antigenic fragment thereof encoded by said sequence, or antibodies that are reactive with said lipoprotein.

### Claim 42 (depends on 31)

A vaccine for combating Brachyspira hyodysenteriae infection, comprising antibodies against a lipoprotein according to claim 31 and a pharmaceutically acceptable carrier.

### Claim 43 (depends on 42)

The vaccine according to claim 42, comprising an adjuvant.

### Claim 44 (depends on 42)

The vaccine according to claim 42, comprising an additional antigen derived from another swine pathogen, an antibody against such an antigen or genetic information encoding said antigen.

### Claim 45 (depends on 44)

The vaccine according to claim 44, wherein said pathogen is selected from the group constituting of Pseudorabies virus, Porcine influenza virus, Porcine parvo virus, Transmissible gastro-enteritis virus, Rotavirus, Escherichia coli, Erysipelo rhusiopathiae, Bordetella bronchiseptica, Salmonella cholerasuis, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis, Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae.
